CMND Key Statistics, Chart & Performance
The current stock price of CMND is 2.68 USD. In the past month the price increased by 19.46%. In the past year, price decreased by -95.14%.
CMND Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CMND. When comparing the yearly performance of all stocks, CMND is a bad performer in the overall market: 99.79% of all stocks are doing better.
CMND Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CMND. CMND scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CMND Financial Highlights
Over the last trailing twelve months CMND reported a non-GAAP Earnings per Share(EPS) of -25.83. The EPS decreased by -102.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -101.99% | ||
| ROE | -378.42% | ||
| Debt/Equity | 0 |
CMND Forecast & Estimates
CMND Ownership
About CMND
Company Profile
Clearmind Medicine Inc is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Company Info
CLEARMIND MEDICINE INC
101-1220 West 6Th Avenue
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16042601566
CLEARMIND MEDICINE INC / CMND FAQ
What does CMND do?
Clearmind Medicine Inc is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
What is the current price of CMND stock?
The current stock price of CMND is 2.68 USD.
What is the dividend status of CLEARMIND MEDICINE INC?
CMND does not pay a dividend.
What is the ChartMill rating of CLEARMIND MEDICINE INC stock?
CMND has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists CMND stock?
CMND stock is listed on the Nasdaq exchange.